Cargando…

Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma

SIMPLE SUMMARY: Glioblastoma multiforme (GBM) is the most aggressive type of brain tumor with dismal survival and poor response to conventional therapies. Therefore, the development of immunotherapy for GBM treatment is necessary. However, the rigorous immunosuppression in the GBM-microenvironment (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Ketao, Mao, Chunsen, Chen, Lin, Wang, Lude, Liu, Yuyao, Yuan, Jianlie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826839/ https://www.ncbi.nlm.nih.gov/pubmed/33435205 http://dx.doi.org/10.3390/cancers13020229

Ejemplares similares

The role of adenosinergic pathway in human autoimmune diseases
por: Dong, Ke, et al.
Publicado: (2016)

From ‘Hellstrom Paradox–to anti-adenosinergic cancer immunotherapy
por: Lukashev, Dmitriy, et al.
Publicado: (2007)

From organ preservation to selective surgery: How immunotherapy changes colorectal surgery?
por: Yao, Shiya, et al.
Publicado: (2023)

The Adenosinergic System in Diabetic Retinopathy
por: Vindeirinho, J., et al.
Publicado: (2016)

Inhibition of the Adenosinergic Pathway in Cancer Rejuvenates Innate and Adaptive Immunity
por: Azambuja, Juliana Hofstätter, et al.
Publicado: (2019)

Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grail
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Adenosinergic System and Neuroendocrine Syncope: What Is the Link?
por: Guieu, Régis, et al.
Publicado: (2023)

Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?
por: Paganelli, Franck, et al.
Publicado: (2021)

Dysregulation of Adenosinergic Signaling in Systemic and Organ-Specific Autoimmunity
por: Vuerich, Marta, et al.
Publicado: (2019)

Adenosinergic axis and immune checkpoint combination therapy in tumor: A new perspective for immunotherapy strategy
por: Liu, Zhaoyun, et al.
Publicado: (2022)

Purinergic and Adenosinergic Signaling in Pancreatobiliary Diseases
por: Faraoni, Erika Y., et al.
Publicado: (2022)

Targeting Hypoxia-A2A Adenosinergic Immunosuppression of Antitumor T Cells During Cancer Immunotherapy
por: Steingold, Joseph M., et al.
Publicado: (2020)

Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy
por: Kurago, Zoya, et al.
Publicado: (2023)

Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?
por: Stepanenko, Aleksei A., et al.
Publicado: (2018)

The CD39-Adenosinergic Axis in the Pathogenesis of Immune and Nonimmune Diabetes
por: Chia, Joanne S. J., et al.
Publicado: (2012)

The Adenosinergic System as a Therapeutic Target in the Vasculature: New Ligands and Challenges
por: Sousa, Joana Beatriz, et al.
Publicado: (2017)

A New Drug Design Targeting the Adenosinergic System for Huntington's Disease
por: Huang, Nai-Kuei, et al.
Publicado: (2011)

The adenosinergic system in cancer: Key therapeutic target
por: Sorrentino, Rosalinda, et al.
Publicado: (2013)

The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis
por: Duarte-Silva, Eduardo, et al.
Publicado: (2022)

Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective
por: Lan, Huanrong, et al.
Publicado: (2020)

Immunotherapy of Neuroblastoma: Facts and Hopes
por: Anderson, John, et al.
Publicado: (2022)

The Role of Tumour Metabolism in Cisplatin Resistance
por: Wang, Lude, et al.
Publicado: (2021)

Prognositic value of CD73-adenosinergic pathway in solid tumor: A meta-analysis and systematic review
por: Wang, Rong, et al.
Publicado: (2017)

Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose?
por: Kotulová, Jana, et al.
Publicado: (2021)

Natural products: a hope for glioblastoma patients
por: Vengoji, Raghupathy, et al.
Publicado: (2018)

Effect of Diabetes/Hyperglycemia on the Rat Retinal Adenosinergic System
por: Vindeirinho, Joana, et al.
Publicado: (2013)

Adenosinergic System Involvement in Ischemic Stroke Patients’ Lymphocytes
por: Pasquini, Silvia, et al.
Publicado: (2020)

Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?
por: Vaisitti, Tiziana, et al.
Publicado: (2018)

Adenosinergic Signaling Alters Natural Killer Cell Functional Responses
por: Chambers, Andrea M., et al.
Publicado: (2018)

The adenosinergic machinery in cancer: In-tandem insights from basic mechanisms to therapy
por: Kang, Chifei, et al.
Publicado: (2023)

Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?
por: Castet, Florian, et al.
Publicado: (2019)

Regulation of Hypoxic–Adenosinergic Signaling by Estrogen: Implications for Microvascular Injury
por: Cassavaugh, Jessica, et al.
Publicado: (2023)

Amyloid-beta immunotherapy: the hope for Alzheimer disease?
por: Barrera-Ocampo, Alvaro, et al.
Publicado: (2016)

CD73 Is a Major Regulator of Adenosinergic Signalling in Mouse Brain
por: Kulesskaya, Natalia, et al.
Publicado: (2013)

The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease
por: Cellai, Lucrezia, et al.
Publicado: (2018)

Adenosinergic Signaling as a Key Modulator of the Glioma Microenvironment and Reactive Astrocytes
por: Debom, Gabriela N., et al.
Publicado: (2022)

Biomarkers for precision immunotherapy in the metastatic setting: hope or reality?
por: Sajjadi, Elham, et al.
Publicado: (2020)

Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy
por: Davar, Diwakar, et al.
Publicado: (2022)

Hope and Challenges: Immunotherapy in EGFR-Mutant NSCLC Patients
por: Yan, Dan
Publicado: (2023)

Effects of Selen on the Antidepressant-like Activity of Agents Affecting the Adenosinergic Neurotransmission
por: Szopa, Aleksandra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bf3eo3eukfo8nborucfog0po0l